{"name":"Vrije Universiteit Brussel","slug":"vrije-universiteit-brussel","ticker":"","exchange":"","domain":"","description":"The Vrije Universiteit Brussel is a Dutch- and English-speaking research university in Brussels, Belgium. It has four campuses: Brussels Humanities, Science and Engineering Campus, Brussels Health Campus, Brussels Technology Campus and Brussels Photonics Campus.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Oral potassium supplements","genericName":"Oral potassium supplements","slug":"oral-potassium-supplements","indication":"Other","status":"marketed"},{"name":"Intravenous bumetanide TID","genericName":"Intravenous bumetanide TID","slug":"intravenous-bumetanide-tid","indication":"Other","status":"marketed"},{"name":"Oral chlorthalidone OD","genericName":"Oral chlorthalidone OD","slug":"oral-chlorthalidone-od","indication":"Other","status":"marketed"},{"name":"Xylocaine with Epinephrine","genericName":"Xylocaine with Epinephrine","slug":"xylocaine-with-epinephrine","indication":"Local and regional anesthesia for surgical and dental procedures","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Methylphenidate Oral Product","genericName":"Methylphenidate Oral Product","slug":"methylphenidate-oral-product","indication":"Attention-deficit/hyperactivity disorder (ADHD)","status":"phase_3"},{"name":"Reboxetine Pill","genericName":"Reboxetine Pill","slug":"reboxetine-pill","indication":"Major depressive disorder","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Lidocaine infiltration","genericName":"Lidocaine infiltration","slug":"lidocaine-infiltration","indication":"Local infiltration anesthesia for minor surgical procedures","status":"marketed"}]}],"pipeline":[{"name":"Oral potassium supplements","genericName":"Oral potassium supplements","slug":"oral-potassium-supplements","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intravenous bumetanide TID","genericName":"Intravenous bumetanide TID","slug":"intravenous-bumetanide-tid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Lidocaine infiltration","genericName":"Lidocaine infiltration","slug":"lidocaine-infiltration","phase":"marketed","mechanism":"Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials to produce local anesthesia.","indications":["Local infiltration anesthesia for minor surgical procedures","Pain relief during wound closure and tissue manipulation"],"catalyst":""},{"name":"Methylphenidate Oral Product","genericName":"Methylphenidate Oral Product","slug":"methylphenidate-oral-product","phase":"phase_3","mechanism":"Methylphenidate blocks the reuptake of dopamine and norepinephrine in the central nervous system, increasing their availability at the synapse.","indications":["Attention-deficit/hyperactivity disorder (ADHD)","Narcolepsy"],"catalyst":""},{"name":"Oral chlorthalidone OD","genericName":"Oral chlorthalidone OD","slug":"oral-chlorthalidone-od","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reboxetine Pill","genericName":"Reboxetine Pill","slug":"reboxetine-pill","phase":"phase_3","mechanism":"Reboxetine selectively inhibits the reuptake of norepinephrine at the presynaptic neuron, increasing norepinephrine availability in the central nervous system.","indications":["Major depressive disorder","Attention deficit hyperactivity disorder (ADHD)"],"catalyst":""},{"name":"Xylocaine with Epinephrine","genericName":"Xylocaine with Epinephrine","slug":"xylocaine-with-epinephrine","phase":"marketed","mechanism":"Xylocaine (lidocaine) blocks sodium channels to produce local anesthesia, while epinephrine causes vasoconstriction to prolong anesthetic duration and reduce systemic absorption.","indications":["Local and regional anesthesia for surgical and dental procedures","Infiltration anesthesia","Nerve blocks"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxOZ0I5ZlRoZGxrRjVYcWEwUHpKdExGSThwVXlVUjQ0Y0JpRXM4UnR2YWVKaHUzbWZUVjRTZDVBQm5XNHVXUU9zaEowOHVtT2NmamlOSGZZNm1pYkM1RklNdFd1MUJFV3BpWHF0RGlXY2tMUmYwUjQtRHZTV3RYSGI4NXNJWDYxR2xiNFlha1VFVUtVT3Bac19qeDdwdkkyV3FxN1pMeE5GMlhrdWtyYl9rbjk4c1NFOHlnYk04Yy1nc3JzVFcwSjJvRml3UUxHOVBOQmc2QXY5YnAwRjdfU1lrUXJHQVd4T2c3R0Zn?oc=5","date":"2026-02-24","type":"pipeline","source":"The Malaysian Reserve","summary":"etherna's intratumoral mRNA/LNP platform advances to clinical testing in nonmelanoma skin cancer led by Almirall - The Malaysian Reserve","headline":"etherna's intratumoral mRNA/LNP platform advances to clinical testing in nonmelanoma skin cancer led by Almirall","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOeFlXbWVXeEN1UjRwcVhzd2ZtckExVUEtSHNTbUh4QlFTV0k4YzBJMm9LT01NV3Mtd21iRlJlLXhvQjhhZ0U3WU1ydlRZajF5VVJqSWl0YkhnelNBVWY1Yk13U0pNUXJvOEFVUDlmYThJVlRhWmFZM3hYME8ycTJKTC16WEFxN3JUcTd6M2U2blYxLTA?oc=5","date":"2026-02-09","type":"pipeline","source":"THISDAYLIVE","summary":"Group Petitions Education Minister Over VC Tussle - THISDAYLIVE","headline":"Group Petitions Education Minister Over VC Tussle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOMjFkQUhfSHFESVo3STI5bnI4SjVOXzFVbldvdjlHZS1GZGpSMkhueXRDMEdrQlNzRWVTRGNZbjA4SENIckJpbHY4QXI0Y2NBWk1Cb0xLSVFmR1g2R0Y1UmdOOWVsR3NDeHdjU1RJNXJscmN3NE5lSnM3QkFGXzk5bjAyeVJjYUhZd0RleXA2bXdrbDlHYUdaemFYN0o4cGFRTEhvNy1mZk8tdWVn?oc=5","date":"2026-02-07","type":"pipeline","source":"TheCable","summary":"Group alleges governor’s brother not qualified for Federal University Wukari VC role - TheCable","headline":"Group alleges governor’s brother not qualified for Federal University Wukari VC role","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOZDBaTUY3LTVqYTdSeGxKNkp0OFF3bEc5MUVralNzNUhBbTBzeEZ2RFJlODdXNmVVWVBzbGJzMUxUU1RGSENFQ2tzTjV6VlVObmFWQWVMN1B4ODRTcE5jWHN5czNlXy11emd3SzY4NzVKcFhSQWVodzlfNWxZakMxU2ZMOFJRVHJlUGlNRy10Q3A0SEltc0kwRTRBVlgtRTR2VTFvZWxyaFdFcmJ2SWFPaXN0OEl0SWg5VU5wcw?oc=5","date":"2025-12-27","type":"pipeline","source":"Chromatography Online","summary":"HPLC 2025 Revisited (Part Two): A Year-End Review of LCGC’s Conference Highlights - Chromatography Online","headline":"HPLC 2025 Revisited (Part Two): A Year-End Review of LCGC’s Conference Highlights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPMTJJSXRnSmRvMXBqazA3QkdXbDlYZHVOc2N5bFFVTVZxWU1Fc2x3TmpvYTV6TnM4NF8zZmhieFRBbGhKOXhfVTVlYzV5T3ZmTGdyN1pLZzdyc1dUcGhhck9HOTNYMjhhYjBrSDVQOFRraUQ5RFFRQXpvVy1TR1RvR3pwNTdMeXQ4dnNacURoVDJPaUZWcTkyckk4UnVwOUhuNE8ydUJ6VEhXZUU1WV9xNGFR?oc=5","date":"2025-12-03","type":"pipeline","source":"Investment & Pensions Europe","summary":"Brussels People – Lieve Wierinck: Building on Europe’s scientific base | Opinion Pieces | IPE - Investment & Pensions Europe","headline":"Brussels People – Lieve Wierinck: Building on Europe’s scientific base | Opinion Pieces | IPE - Investment & Pensions Eu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Ub3hMQnFxb1RnNFBSc3UyT1Q3OFhZVEdJdW1na2xlbEVPcHJpam5FYTlQZnBrUDhoREpQZVg5cGFGZEZwblpTVWFvX1VYcUpCN244WXZGaUZJbGxXOWhJ?oc=5","date":"2025-11-25","type":"pipeline","source":"nature.com","summary":"1q gain bypasses the selective barrier against aneuploidy in RPE differentiation via wild-type co-culture rescue - nature.com","headline":"1q gain bypasses the selective barrier against aneuploidy in RPE differentiation via wild-type co-culture rescue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNVUycW1weTBvQklFQXhnb2tHSTl6cnh1NVBvdkI2bnRsNnF6NmJDVHljczdSVXpIaUE5cW92SjJuWUxoa0lRZHBqVDRyMHVDaGs4ZXZwRUtEdE5qcFJ3bnRQbVdNUnhiZlBlV1ZLbW5MWVN5XzVualVIU2tuYzBBRnZGdkNybUN6cWZReFFDM19LRE5jUmJnZW9B?oc=5","date":"2025-10-24","type":"trial","source":"Frontiers","summary":"Implementation of Medication Review Type 2a in Community Pharmacies: A Longitudinal Survey Study - Frontiers","headline":"Implementation of Medication Review Type 2a in Community Pharmacies: A Longitudinal Survey Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUEk5QkpkOU8xdFRPLU8zcHBYNG1uV0swS2VDeUhCbDNGY2t0U2NKbW5OQV9RRUtEUXZUTnRkM2lTem5kTFotRjI1cmxHdThpS1pPMFFua1pyUDhvajdUZlJLN2lmYVpRVGdCVkpnbUc3X3ppOXVEU3dnMjJFVy1OOGJyTW5RVENFTlBhMi1R?oc=5","date":"2025-06-17","type":"trial","source":"Medical Xpress","summary":"Intensive guidance of COPD patients by hospital pharmacists shows clear added value, finds study - Medical Xpress","headline":"Intensive guidance of COPD patients by hospital pharmacists shows clear added value, finds study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQb0E3WnpPalN1VVFRWGNZNkllWE52QXU2VTkwa0Z4Z19mdmFqR1Rab2tPVU9fSlItb2pIcUhudEtFTEw2cmFYTmN3LXQ4OU1kTk1kaGwybVlFTGJaaGtQQzV0b2FNdnkzRHpRT0M2NHVhUzlGSXRNbzd1Q3lHcm5VZGZ0c2tNYWxVQnAyZTEzUk03dXRnYkFEY0JObjBuY1hCa0ZmVlZ2dTR2X3dZcmt0Z0dGdV8zZnBnNmVHUndkZjRsZmd4b2c?oc=5","date":"2025-03-21","type":"pipeline","source":"Fierce Biotech","summary":"European countries, universities implement initiatives to attract US researchers amid 'brutal funding cuts' - Fierce Biotech","headline":"European countries, universities implement initiatives to attract US researchers amid 'brutal funding cuts'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1uZmx0cEtxTl9IV2k3QUpHSGVlOXc4NEoxcmU0NkZIdkdLS3IwVUxuckpvT2hobmhDU3FVVFYwTW5XWm5TR085cFJFSC1oRzlGalFTWTUxWVdfcVBSZWxBSF9NbXBpZ09jMnc?oc=5","date":"2024-08-08","type":"pipeline","source":"Wiley Online Library","summary":"Hepatic cell junctions: Pulling a double‐duty - Van Campenhout - 2024 - Liver International - Wiley Online Library","headline":"Hepatic cell junctions: Pulling a double‐duty - Van Campenhout - 2024 - Liver International","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE8yYWpDNHhSSUhaelNpZTM3WTh2cFVDcDc4RlFTcXA3OG1nRFVHZmFETmNhVEJYYWtkSjZGaktsS1ZaTGlWR2YzM3BGV1dDY0syYjVJbklWNW9QTHhITXV2TA?oc=5","date":"2024-07-01","type":"pipeline","source":"The Pharma Letter","summary":"Confo Therapeutics - The Pharma Letter","headline":"Confo Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPTFNqUlNPSWk4RFhDdWxTRWwySEkzd0lrZ2pJYzY3UWdILVgxbnFQd0xFOEowTTY2QXVibWhQSEVkQzl0N1JFR3B1UHkxSDVPVkZ6THMyNmN3bnpVeWc4Q2trVlJ5V3o3ZExSeFRWQjF6YS1XR2Q3Vmx5YUZIenlZRERuSXI0TmZpdWNOc2dlZ2tiOEJRQ3c?oc=5","date":"2022-03-16","type":"pipeline","source":"pharmaphorum","summary":"Belgium's Precirix raises €80m to fund radiopharma aspirations - pharmaphorum","headline":"Belgium's Precirix raises €80m to fund radiopharma aspirations","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"marketed":5,"phase_3":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}